# Neumora Therapeutics, Inc.: Form SC 13D/A, filed Nov 22, 2024

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: SC 13D/A
- Filed: 2024-11-22
- Accepted by EDGAR: Nov 22, 2024, 17:33 ET
- Period: not reported
- Accession: 0001072613-24-000899
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000107261324000899/arch-sch13d_18910.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000107261324000899/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000107261324000899/arch-sch13d_18910.htm

Filed Nov 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000899. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.